Which statement best reflects a class of antiemetic agents commonly used for N/V management?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

A multimodal approach to nausea and vomiting relies on several drug classes that interrupt different pathways involved in the vomiting reflex. Anticholinergics (for example, scopolamine) block muscarinic receptors in the vestibular system and gut, helping especially with motion-related and postural nausea. Antihistamines (like diphenhydramine or meclizine) block H1 receptors, providing antiemetic effects and extra sedation which can aid some patients. Steroids (such as dexamethasone) have antiemetic effects that are useful in chemotherapy- and postoperative-related N/V, though their exact mechanism isn’t fully understood. Prokinetics (metoclopramide, domperidone) enhance gastric emptying and also act as dopamine antagonists with additional antiemetic effects. Benzodiazepines (lorazepam, diazepam) help reduce anxiety and anticipatory nausea, often used as adjuncts. 5-HT3 receptor antagonists (ondansetron, granisetron) block serotonin receptors in the gut and the chemoreceptor trigger zone, making them highly effective across several types of N/V, including chemotherapy- and postoperative-induced forms.

These classes collectively address multiple etiologies and pathways of nausea and vomiting, which is why they are commonly used together. Other options listed, such as antibiotics, vaccines, or immunoglobulins, do not function as antiemetic agents and don’t target the vomiting pathways.